Status:
WITHDRAWN
Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Lead Sponsor:
Prima BioMed Ltd
Conditions:
Pancreatic Carcinoma Stage I
Pancreatic Carcinoma Stage II
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and tolerability of CVac, an investigational cell therapy, in patients with resected stage I or II adenocarcinoma of the pancreas who have completed s...
Detailed Description
A total of approximately 40 patients at up to 30 clinical sites will be screened for eligibility into the study within 6 weeks of completing treatment, including R0 (complete resection with no microsc...
Eligibility Criteria
Inclusion
- Histologically or cytologically diagnosed adenocarcinoma of the pancreas, stage I or stage II disease
- Postoperative confirmed R0 or R1 resection status with no evidence of residual disease based on radiographic Imaging
- CA 19-9 less than 2 × the ULN by the central laboratory
- No greater than 6 weeks since completion of prior therapy, which includes surgery with or without radiation or chemotherapy
- Mucin 1-positive tumor as determined by central immunohistopathology. Sites will be asked to submit archival tissue (patients may start the study if tissue is available at an outside hospital, but not yet requested or received)
- Signed an informed consent form (ICF)
- Willing and able to complete study procedures within the study timelines
- Life expectancy of at least 6 months in the investigator's opinion
- ≥ 18 years of Age
- ECOG performance status \< 2 (Karnofsky ≥ 70%)
- Normal organ and marrow function: serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 × ULN and serum bilirubin ≤ 1.5 × ULN unless Gilbert's syndrome has previously been confirmed for the patient, white blood cells (WBCs) ≥ 3.0 K/µL, absolute neutrophil count (ANC) ≥ 1.0 × 109/L, hemoglobin ≥ 8 g/dL, and platelets ≥ 100 × 109/L
- Not pregnant, and if of childbearing potential, agrees to use a highly effective method of birth control (implanted, injectable, or oral combination hormonal method alone or in possible combinations, intrauterine device, vasectomized partner, or abstinence) prior to study entry, for the duration of the study, and for 3 months after the last dose of Cvac. Male partners of a study patient must use a condom in addition to the acceptable method of contraception for the female partner as specified above
Exclusion
- Active, acute, or chronic clinically significant infections or bleeding
- Uncontrolled hypertension (systolic blood pressure \> 150 mmHg or diastolic blood pressure \> 100 mmHg) or history of congestive heart failure (≥ Grade 2)
- Active angina pectoris, stroke, or recent myocardial infarction (within 6 months)
- Additional uncontrolled, serious medical or psychiatric illness
- Evidence or history of central nervous system metastases
- Inadequate renal function defined as a creatinine clearance \< 60 mL/min as determined by the central laboratory
- Additional malignancy diagnosed within 5 years of study enrollment, except carcinoma in situ of the cervix or basal cell and squamous cell carcinomas of the skin
- Treatment with any other investigational agent (for any condition) within 4 weeks of Screening
- Infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), or syphilis (Treponema pallidum \[TPHA\])
- Concurrent systemic treatment with steroids or other immunosuppressant agents at a dose considered by the investigator to be higher than a standard physiological dose
- Active autoimmune disease; any previous autoimmune disease must not require chronic treatment in the 6 months prior to screening
- Germany only:
- Oversensitivity to the substances or another component of the investigational medicinal product
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02310971
Start Date
February 1 2015
End Date
March 1 2015
Last Update
April 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.